TMCnet News

Research and Markets: China Hospital Development and Investment Forecasts Report, 2017
[November 26, 2014]

Research and Markets: China Hospital Development and Investment Forecasts Report, 2017


DUBLIN --(Business Wire)--

Research and Markets: China Hospital Development and Investment Forecasts Report, 2017Research and Markets (http://www.researchandmarkets.com/research/cx762b/china_hospital) has announced the addition of the "China Hospital Development and Investment Report, 2014-2017" report to their offering.

In the private hospital investment boom, specialized hospitals involved with small investment, high returns and strong market demand have become a hotspot for social capital. Currently, the proportion of Chinese specialized hospitals in private hospitals reaches about 65%. Specialized hospitals in huge demand, such as dental hospitals, ophthalmic hospitals, plastic surgery & cosmetic hospitls, even achieve the profit margins of more than 10%, much higher than the overall level of Chinese hospitals (about 5%).



The enterprises focusing on medicine, including Shanghai Fosun Pharmaceutical, Jinling Pharmaceutical, Inner Mongolia Furui Medical Science, Wuhan Jianmin Pharmaceutical, Yibai Pharmaceutical, China Resources Sanjiu and Kangmei Pharmaceutical, are actively extending to downstream medical services. Shanghai Fosun Pharmaceutical has stepped in obstetrics & gynecology, tumor and other areas through mergers and acquisitions; its revenue from hospital medical services reached RMB474.6 million in 2013, representing a substantial increase of 215.6% over previous year.

Targeting medium and high-end medical markets, foreign-funded enterprises mainly adopt cooperative operation, equity participation, joint ventures (under the lead of foreign investors) and other approaches to develop business in China, such as Chindex United Family Hospital and Parkway Pantai. United Family Hospital had covered Beijing, Shanghai, Wuxi, Guangzhou and Tianjin by the end of June 2014, and its hospitals in Qingdao and Guangzhou are under construction.


Key Topics Covered:

1. Overview of China Hospital Industry

2. Overview of China Hospital Market

3. Current Development of Specialized Hospitals in China

4. Development Forecast of China Hospital Industry

5. Investment in China Hospital Industry

6 Major Chinese Enterprises

7 Summary and Forecast

Companies Mentioned

  • Aier Eye Hospital Group
  • CMS Holdings Ltd.
  • China Resources Sanjiu
  • Inner Mongolia Furui Medical Science
  • Jiangnan Mould & Plastic Technology
  • Jinling Pharmaceutical
  • Kangmei Pharmaceutical
  • Mayinglong Pharm
  • Parkway Pantai
  • Phoenix Healthcare
  • Shanghai Fosun Pharmaceutical
  • Shinva Medical
  • TC Medical
  • United Family Hospital
  • Wuhan Jianmin Pharmaceutical
  • Xi'an Kaiyuan Investment
  • Yibai Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/cx762b/china_hospital


[ Back To TMCnet.com's Homepage ]